Penn Medicine Rittenhouse is a rehabilitation and long-term acute-care facility in the Southwest Center City neighborhood of Philadelphia founded in 2007. The current facility is owned by the University of Pennsylvania Health System and operated by Good Shepherd Penn Partners.

There are 95 beds in Penn Medicine Rittenhouse.

During the past decade, Penn Medicine Rittenhouse conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 1 clinical trials were completed, i.e. on average, 16.7% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 1 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Penn Medicine Rittenhouse" #1 collaborator was "Children's Hospital of Philadelphia" with 1 trials as a collaborator, "Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)" with 1 trials as a collaborator, "Mercy Living Independently for Elders (LIFE) - West Philadelphia (Trinity Health Pace)" with 1 trials as a collaborator, "National Institute on Aging (NIA)" with 1 trials as a collaborator and "Recupero Robotics LLC" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 7 trials.

According to Clinical.Site data, the most researched conditions in "Penn Medicine Rittenhouse" are "Stroke" (8 trials), "Cerebral Palsy" (3 trials), "HIV Infections" (3 trials), "Hemiplegia" (3 trials) and "Healthy" (2 trials). Many other conditions were trialed in "Penn Medicine Rittenhouse" in a lesser frequency.

Most popular intervention types in "Penn Medicine Rittenhouse" are "Device" (8 trials), "Drug" (4 trials) and "Other" (3 trials). Other intervention types were less common.

The name of intervention was led by "Doxorubicin hydrochloride (liposomal)" (2 trials), "Bi-ADLER" (1 trials), "Bilateral assessment robots (BiAS)" (1 trials), "Bleomycin sulfate" (1 trials) and "Doxorubicin hydrochloride" (1 trials). Other intervention names were less common.

The vast majority of trials in "Penn Medicine Rittenhouse" are 14 trials for "All" genders.

Currently, there are NaN active trials in "Penn Medicine Rittenhouse". undefined are not yet recruiting, 3 are recruiting, 1 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 5 completed trials in Penn Medicine Rittenhouse, 1 suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Penn Medicine Rittenhouse, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 8 trials that are defined as “Not Applicable".